FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1951361257> ?p ?o ?g. }

• W1951361257 endingPage "35" @default.
• W1951361257 startingPage "5529" @default.
• W1951361257 abstract "The cytotoxicity and metabolic effects of two thymidylate synthase (TS) inhibitors, Tomudex (Raltitrexed, ZD1694) and GW1843U89, were studied in WiDr colon cancer cells under four different growth conditions: as standard monolayers and as postconfluent multilayers grown under either high (WiDr, 8.8 microM folic acid) or low (WiDr/F, 1 nM leucovorin) folate conditions. Both GW1843U89 and ZD1694 were 13-15-fold more active against WiDr/F than WiDr cells when cultured as monolayers (IC50s in WiDr/F cells were 0.22 and 0.39 nM, respectively). WiDr cells were markedly less sensitive to the drugs when grown as multilayers (4-15-fold), in contrast to the WiDr/F cells, which were equally sensitive. However, total growth inhibition could not be achieved in WiDr multilayers (concentration causing total growth inhibition > 10,000 nM), whereas in WiDr/F multilayers, it could be achieved at 0.42 nM ZD1694 and 150 nM GW1843U89. Growth conditions markedly affected the TS levels when using different enzyme assays. At nonsaturating substrate concentrations, the catalytic activity of TS was similar in mono- and multilayers grown under high folate conditions but lower in multilayers at saturating concentrations. In cells grown under low folate conditions, TS catalytic activity was 3-6-fold lower in multilayers than in monolayers. This was consistent with a decrease in the number of S-phase cells in multilayers. Western blotting revealed less pronounced (2-3-fold) differences in the TS protein content. Exposure of the cells for 24 h to the drugs increased the TS levels by 4-fold. Because this increase in TS levels might explain the decrease in sensitivity to the TS inhibitors, we measured TS inhibition (TSI) by the drugs in intact cells using the TS in situ assay. GW1843U89 was more active than ZD1694. However, after 4 h of exposure in WiDr/F mono- and multilayers, TSI was in the same range for both drugs [50% TSI (TSI50), 0.5-1.7 nM]. In WiDr cells, the TSI50 for ZD1694, but not GW1843U89, was 10 times higher in the multilayers as compared to the monolayers. Despite the increase in TS protein levels, the extent of TSI was similar or even more pronounced in both cell lines grown as either multi- or monolayers. Because the cells were grown under depleted and folate-rich conditions that may affect folate uptake, we measured folate transport using methotrexate (MTX) as the reference drug for the activity of the reduced folate carrier. MTX uptake was 4-fold lower in multilayers compared to monolayers in both WiDr and WiDr/F cells. Uptake of MTX was 5-fold more effective in WiDr/F cells than in WiDr cells in both mono-and multilayers. In conclusion, the resistance of WiDr multilayers to the novel antifolates ZD1694 and GW1843U89 may be due to the high folate medium concentrations, which may be responsible for impaired drug uptake along with less effective TSI. In contrast, WiDr/F monolayers and multilayers were very sensitive to these antifolates. These effects of folate homeostasis may explain some of the variable results seen in treatment of solid tumors with new antifolate TS inhibitors." @default.
• W1951361257 created "2016-06-24" @default.
• W1951361257 creator A5007946879 @default.
• W1951361257 creator A5036871568 @default.
• W1951361257 creator A5044707786 @default.
• W1951361257 creator A5062035206 @default.
• W1951361257 creator A5072692879 @default.
• W1951361257 date "1999-11-01" @default.
• W1951361257 modified "2023-10-11" @default.
• W1951361257 title "Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions." @default.
• W1951361257 cites W1500496616 @default.
• W1951361257 cites W1551928250 @default.
• W1951361257 cites W1578622010 @default.
• W1951361257 cites W1605870370 @default.
• W1951361257 cites W1831534333 @default.
• W1951361257 cites W1870840348 @default.
• W1951361257 cites W1878778078 @default.
• W1951361257 cites W1880102547 @default.
• W1951361257 cites W1888458155 @default.
• W1951361257 cites W1964736779 @default.
• W1951361257 cites W1965104493 @default.
• W1951361257 cites W1967802960 @default.
• W1951361257 cites W1977977906 @default.
• W1951361257 cites W1983618647 @default.
• W1951361257 cites W1985364084 @default.
• W1951361257 cites W1988443167 @default.
• W1951361257 cites W1992022488 @default.
• W1951361257 cites W1993899589 @default.
• W1951361257 cites W2003336233 @default.
• W1951361257 cites W2013553237 @default.
• W1951361257 cites W2018366596 @default.
• W1951361257 cites W2026018236 @default.
• W1951361257 cites W2032360922 @default.
• W1951361257 cites W2039545457 @default.
• W1951361257 cites W2054814252 @default.
• W1951361257 cites W2075732321 @default.
• W1951361257 cites W2078291647 @default.
• W1951361257 cites W2079752673 @default.
• W1951361257 cites W2082973931 @default.
• W1951361257 cites W2088996957 @default.
• W1951361257 cites W2106770772 @default.
• W1951361257 cites W2110083695 @default.
• W1951361257 cites W2113138482 @default.
• W1951361257 cites W2113156630 @default.
• W1951361257 cites W2115231119 @default.
• W1951361257 cites W2126486896 @default.
• W1951361257 cites W2128635872 @default.
• W1951361257 cites W2131232623 @default.
• W1951361257 cites W2135935949 @default.
• W1951361257 cites W2166199856 @default.
• W1951361257 cites W2316518752 @default.
• W1951361257 cites W235834215 @default.
• W1951361257 cites W2418251045 @default.
• W1951361257 cites W2422445773 @default.
• W1951361257 cites W2429567348 @default.
• W1951361257 cites W302620442 @default.
• W1951361257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10554030" @default.
• W1951361257 hasPublicationYear "1999" @default.
• W1951361257 type Work @default.
• W1951361257 sameAs 1951361257 @default.
• W1951361257 citedByCount "9" @default.
• W1951361257 countsByYear W19513612572015 @default.
• W1951361257 countsByYear W19513612572016 @default.
• W1951361257 countsByYear W19513612572019 @default.
• W1951361257 crossrefType "journal-article" @default.
• W1951361257 hasAuthorship W1951361257A5007946879 @default.
• W1951361257 hasAuthorship W1951361257A5036871568 @default.
• W1951361257 hasAuthorship W1951361257A5044707786 @default.
• W1951361257 hasAuthorship W1951361257A5062035206 @default.
• W1951361257 hasAuthorship W1951361257A5072692879 @default.
• W1951361257 hasConcept C109316439 @default.
• W1951361257 hasConcept C121608353 @default.
• W1951361257 hasConcept C123321153 @default.
• W1951361257 hasConcept C126322002 @default.
• W1951361257 hasConcept C181199279 @default.
• W1951361257 hasConcept C185592680 @default.
• W1951361257 hasConcept C202751555 @default.
• W1951361257 hasConcept C2778397455 @default.
• W1951361257 hasConcept C2779268555 @default.
• W1951361257 hasConcept C2780456651 @default.
• W1951361257 hasConcept C2781382166 @default.
• W1951361257 hasConcept C55493867 @default.
• W1951361257 hasConcept C62112901 @default.
• W1951361257 hasConcept C71924100 @default.
• W1951361257 hasConcept C86803240 @default.
• W1951361257 hasConceptScore W1951361257C109316439 @default.
• W1951361257 hasConceptScore W1951361257C121608353 @default.
• W1951361257 hasConceptScore W1951361257C123321153 @default.
• W1951361257 hasConceptScore W1951361257C126322002 @default.
• W1951361257 hasConceptScore W1951361257C181199279 @default.
• W1951361257 hasConceptScore W1951361257C185592680 @default.
• W1951361257 hasConceptScore W1951361257C202751555 @default.
• W1951361257 hasConceptScore W1951361257C2778397455 @default.
• W1951361257 hasConceptScore W1951361257C2779268555 @default.
• W1951361257 hasConceptScore W1951361257C2780456651 @default.
• W1951361257 hasConceptScore W1951361257C2781382166 @default.
• W1951361257 hasConceptScore W1951361257C55493867 @default.
• W1951361257 hasConceptScore W1951361257C62112901 @default.

• next